Found: 14
Select item for more details and to access through your institution.
Selected pharmacotherapy agents as antiproliferative and anti‐inflammatory compounds.
- Published in:
- Drug Development Research, 2020, v. 81, n. 4, p. 470, doi. 10.1002/ddr.21640
- By:
- Publication type:
- Article
Novel 3‐aryl‐5‐substituted‐coumarin analogues: Synthesis and bioactivity profile.
- Published in:
- Drug Development Research, 2020, v. 81, n. 4, p. 456, doi. 10.1002/ddr.21639
- By:
- Publication type:
- Article
Opportunities and challenges of using five‐membered ring compounds as promising antitubercular agents.
- Published in:
- Drug Development Research, 2020, v. 81, n. 4, p. 402, doi. 10.1002/ddr.21638
- By:
- Publication type:
- Article
Synthesis of novel flexible tamoxifen analogues to overcome CYP2D6 polymorphism and their biological evaluation on MCF‐7 cell line.
- Published in:
- Drug Development Research, 2020, v. 81, n. 4, p. 444, doi. 10.1002/ddr.21637
- By:
- Publication type:
- Article
Cover Image, Volume 81, Issue 4.
- Published in:
- Drug Development Research, 2020, v. 81, n. 4, p. i, doi. 10.1002/ddr.21702
- Publication type:
- Article
Oridonin ameliorates carbon tetrachloride‐induced liver fibrosis in mice through inhibition of the NLRP3 inflammasome.
- Published in:
- Drug Development Research, 2020, v. 81, n. 4, p. 526, doi. 10.1002/ddr.21649
- By:
- Publication type:
- Article
Targeting neutrophils using novel drug delivery systems in chronic respiratory diseases.
- Published in:
- Drug Development Research, 2020, v. 81, n. 4, p. 419, doi. 10.1002/ddr.21648
- By:
- Publication type:
- Article
Paeoniflorin alleviates lipopolysaccharide‐induced disseminated intravascular coagulation by inhibiting inflammation and coagulation activation.
- Published in:
- Drug Development Research, 2020, v. 81, n. 4, p. 517, doi. 10.1002/ddr.21647
- By:
- Publication type:
- Article
Pivotal cytokines and their transcription factors are the targets of guluronic acid (G2013) for inhibiting the immunopathogenesis process of multiple sclerosis.
- Published in:
- Drug Development Research, 2020, v. 81, n. 4, p. 511, doi. 10.1002/ddr.21645
- By:
- Publication type:
- Article
Development and characterization of oxaceprol‐loaded poly‐lactide‐co‐glycolide nanoparticles for the treatment of osteoarthritis.
- Published in:
- Drug Development Research, 2020, v. 81, n. 4, p. 501, doi. 10.1002/ddr.21642
- By:
- Publication type:
- Article
Discovery of a novel fluorescent chemical probe suitable for evaluation of neuropilin‐1 binding of small molecules.
- Published in:
- Drug Development Research, 2020, v. 81, n. 4, p. 491, doi. 10.1002/ddr.21641
- By:
- Publication type:
- Article
Oxalomalate regulates the apoptosis and insulin secretory capacity in streptozotocin‐induced pancreatic β‐cells.
- Published in:
- Drug Development Research, 2020, v. 81, n. 4, p. 437, doi. 10.1002/ddr.21635
- By:
- Publication type:
- Article
Issue Information ‐ TOC.
- Published in:
- Drug Development Research, 2020, v. 81, n. 4, p. 389, doi. 10.1002/ddr.21551
- Publication type:
- Article
A review of phenformin, metformin, and imeglimin.
- Published in:
- Drug Development Research, 2020, v. 81, n. 4, p. 390, doi. 10.1002/ddr.21636
- By:
- Publication type:
- Article